Breaking News Instant updates and real-time market news.

MAT

Mattel

$15.05

0.18 (1.21%)

, HAS

Hasbro

$94.99

1.75 (1.88%)

10:44
09/20/17
09/20
10:44
09/20/17
10:44

Toymakers in focus after Toys"R"Us files for bankruptcy, Amazon could benefit

Shares of toymakers, including Mattel (MAT) and Hasbro (HAS), are in focus on Tuesday morning following news that Toys"R"Us has filed for bankruptcy protection ahead of the critical holiday season. TOYS"R"US BANKRUPTCY: Toy retailer Toys"R"Us, which was acquired by private equity firms KKR (KKR) and Bain as well as real estate firm Vornado (VNO) over a decade ago and has struggled in recent years to compete with Amazon (AMZN) and Wal-Mart (WMT), officially filed for Chapter 11 bankruptcy on Monday night in federal court in Richmond, Virginia. The company said it has received a commitment for over $3B in debtor-in-possession financing from various lenders, including a JPMorgan (JPM)-led bank syndicate and certain of the company's existing lenders, which, subject to court approval, is expected to immediately improve the company's financial health and support its ongoing operations during the court-supervised process, the retailer said. Toys"R"Us said it is committed to working with its vendors "to help ensure that inventory levels are maintained and products continue to be delivered in a timely fashion." With its bankruptcy filing, Toys"R"Us becomes another casualty of the fast-changing retail industry, joining children's clothing retailer Gymboree and Payless ShoeSource. RETAILERS MOST EXPOSED: Jefferies analyst Stephanie Wissink noted earlier this month that the top three retailers most exposed to Toys"R"Us are Mattel, Hasbro and JAKKS Pacific (JAKK). Toys"R"Us made up 11%, 9%, 15%, of Hasbro, Mattel and JAKKS revenue in 2016, respectively, Wissink told clients. In a research note on Tuesday, Wissink said that the bankruptcy is "likely to create some dislocation among the vendor roster," and that companies like Hasbro and JAKKS are "strongly positioned" to maintain their financials and pursue brand consolidation opportunities. "We do not expect the bankruptcy event to trigger a domino effect in toy retail, implying massive discounting systemwide that pressures vendor margins on a sustained basis," Wissink added. TRU FILING 'POSITIVE' FOR AMAZON, WAL-MART: Separately, KeyBanc analyst Edward Yruma said this morning that the Toys"R"Us bankruptcy filing is likely to be "positive" for both Amazon and Wal-Mart, noting that baby and toy have been "strategic" categories for Amazon for years and that Wal-Mart should gain market share in the consolidating market. PRICE ACTION: In morning trading, shares of Mattel are up 0.13% to $15.07, JAKKS is up 2.65% to $2.90, and Hasbro is down 0.47% to $94.54.

MAT

Mattel

$15.05

0.18 (1.21%)

HAS

Hasbro

$94.99

1.75 (1.88%)

JAKK

JAKKS Pacific

$2.83

-0.025 (-0.88%)

KKR

KKR

$19.24

0.15 (0.79%)

VNO

Vornado

$73.34

-0.03 (-0.04%)

AMZN

Amazon.com

$969.86

-4.33 (-0.44%)

WMT

Wal-Mart

$80.29

0.24 (0.30%)

JPM

JPMorgan

$94.12

0.18 (0.19%)

  • 23

    Sep

  • 02

    Oct

  • 10

    Oct

  • 12

    Oct

  • 22

    Oct

  • 23

    Oct

  • 16

    Nov

  • 21

    Nov

  • 20

    Feb

  • 27

    Feb

  • 13

    Apr

  • 14

    Jul

  • 12

    Oct

MAT Mattel
$15.05

0.18 (1.21%)

09/07/17
JEFF
09/07/17
NO CHANGE
JEFF
Jefferies lays out retailers most exposed to Toys R Us
Following yesterday's media report that Toys R Us could file for bankruptcy protection, Jefferies analyst Stephanie Wissink notes the chain is in the top three retailers for Hasbro (HAS), Mattel (MAT) and JAKKS Pacific (JAKK). Toys R Us made up 11%, 9%, 15%, of Hasbro, Mattel and JAKKS revenue in 2016, respectively, Wissink tells investors in a research note. She believes, however, that this revenue share would be shifted to alternative channels. Industry demand is resilient to these types of impacts, given the growing alternative channels for purchase, the analyst contends. Wissink thinks any retail fallout from a Toys R Us bankruptcy would be temporary.
08/03/17
08/03/17
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Teva (TEVA) downgraded to Perform from Outperform at Oppenheimer with analyst Derek Archila saying he no longer sees a "clear path" for Teva to return to growth in a "timely manner" amid continued pricing pressure in U.S. generics. 2. Charter (CHTR) downgraded to Neutral from Buy at Guggenheim with analyst Michael Morris citing valuation and increased his price target to $400 from $370. 3. Allstate (ALL) downgraded to Hold from Buy at Deutsche Bank with analyst Joshua Shanker citing valuation. 4. Mattel (MAT) downgraded to Underperform from Neutral at DA Davidson with analyst Linda Bolton Weiser saying she left a recent management meeting with a more cautious outlook for the company's performance in the second half of 2017. 5. Lam Research (LRCX) downgraded to Neutral from Buy at Citi with analyst Atif Malik saying he's becoming more selective in the Semiconductor Capital Equipment space. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
08/30/17
KEYB
08/30/17
INITIATION
KEYB
Sector Weight
Mattel resumed with a Sector Weight at KeyBanc
KeyBanc analyst Brett Andress resumed coverage of Mattel with a Sector Weight rating.
09/05/17
09/05/17
NO CHANGE

BMO Capital lowers toy makers' targets on lackluster film performance
BMO Capital analyst Gerrick Johnson lowered his price target on Hasbro (HAS) to $90 from $95 and on Mattel (MAT) to $23 from $25 citing the weak performance of movies this year and the large number of toy-oriented moves set to be released for the rest of this year and in 2018. He keeps an Outperform rating on Mattel and a Market Perform rating on Hasbro.
HAS Hasbro
$94.99

1.75 (1.88%)

08/30/17
KEYB
08/30/17
INITIATION
Target $112
KEYB
Overweight
Hasbro resumed with an Overweight from Sector Weight at KeyBanc
KeyBanc analyst Brett Andress resumed coverage of Hasbro with an Overweight rating and $112 price target. The firm previously had a Sector Weight rating on the name.
07/25/17
DADA
07/25/17
NO CHANGE
DADA
Hasbro should be bought on weakness, says DA Davidson
DA Davidson analyst Linda Bolton Weiser says that Hasbro reported "solid" results, and the analyst expects the company's gross margins to rebound in 2H17. She thinks the revenue from Partner Brands should accelerate to a 7% increase in Q3, up from a 1% increase in Q2, driven by sales of Star Wars toys. The analyst raised her price target to $121 from $118 and recommends buying the stock on weakness.
JAKK JAKKS Pacific
$2.83

-0.025 (-0.88%)

12/30/16
PIPR
12/30/16
NO CHANGE
PIPR
Piper's checks point to sluggish toy sales
Piper Jaffray analyst Stephanie Wissink said yesterday that her channel checks through post-Christmas have continued to point to below plan sales across the toy category. She believes holiday toy sales are looking to be flat/down low-single-digits, at best. Stock weakness across toys appears to be "fairly factoring in weakness in Q4 and potential inventory correction measures," Wissink wrote to investors. She sees some risk to 2017 consensus estimates and notes that if she had to pick, she'd prefer shares of Hasbro (HAS) in the space. The analyst has a Neutral rating on Hasbro along with JAKKS Pacific (JAKK) and Mattel (MAT).
06/08/17
JEFF
06/08/17
INITIATION
Target $4.5
JEFF
Hold
JAKKS Pacific initiated with a Hold at Jefferies
Jefferies analyst Stephanie Wissink initiated JAKKS Pacific with a Hold and a $4.50 price target saying execution has been somewhat "spotty" and said he would get more constructive on the shares if owned IP investment helped to rebalance the sales mix.
05/23/17
DADA
05/23/17
INITIATION
Target $5
DADA
Neutral
JAKKS Pacific initiated with a Neutral at DA Davidson
DA Davidson analyst Linda Bolton Weiser started JAKKS Pacific with a Neutral rating and $5 price target. The retailer has reported sales declines in five of the last six years, with another decline expected in 2017, despite strong toy industry growth, the analyst writes.
KKR KKR
$19.24

0.15 (0.79%)

08/09/17
BARD
08/09/17
NO CHANGE
BARD
Neutral
AmerisourceBergen settlement ups odds of PharMerica switch, says Baird
Baird analyst Eric Coldwell said AmerisourceBergen's (ABC) 10-Q last week showed that the company and PharMerica (PMC) have tentatively agreed to settle their long-running legal fight, which he reads as significantly increasing the odds of AmerisourceBergen displacing incumbent Cardinal Health (CAH) after KKR (KKR) and minority investor Walgreens (WBA) complete their deal to buy PharMerica. Coldwell has a Neutral rating and $89 price target on AmerisourceBergen shares.
07/25/17
LEER
07/25/17
DOWNGRADE
Target $66.5
LEER
Market Perform
WebMD downgraded to Market Perform from Outperform at Leerink
Leerink analyst David Larsen downgraded WebMD (WBMD) to Market Perform from Outperform after the company announced that it has entered into a definitive agreement to be acquired by Internet Brands, a KKR (KKR) portfolio company, in a transaction valued at about $2.8B. The analyst also raised his price target on WebMD's shares to $66.50 from $60.
05/09/17
NEED
05/09/17
NO CHANGE
Target $16
NEED
Buy
KKR adds $5 per share to Pandora value, says Needham
Noting that Pandora (P) announced it had raised $150M by selling a 5-year, 8% convertible preferred security to KKR (KKR), Needham analyst Laura Martin calculates that adding KKR to the Pandora story adds $5 per share to the latter's value, implying that it should trade up to $15 per share on the news over time. The analyst believes KKR provides a financial safety net, and expects KKR's exit time frame to be 5 years, giving public shareholders a clearer exit path. She reiterates a Buy rating and $16 price target on Pandora's shares.
05/09/17
PIPR
05/09/17
NO CHANGE
Target $18
PIPR
Overweight
Pandora sale path accelerated with KKR investment, says Piper Jaffray
Piper Jaffray analyst Stan Meyers believes Pandora's (P) path towards a potential sale has accelerated following KKR's (KKR) strategic investment. The analyst also expects Pandora's margins in its core radio business to continue improving. He remains "upbeat" on the shares with an Overweight rating and $18 price target.
VNO Vornado
$73.34

-0.03 (-0.04%)

08/30/17
08/30/17
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Otonomy (OTIC) downgraded to Neutral from Overweight at JPMorgan with analyst Anupam Rama citing the company's failed Phase 3 trial of Otividex. The analyst cut his price target for the shares to $8 from $28. 2. Arc Logistics (ARCX) downgraded to Hold from Buy at Stifel and SunTrust. 3. The Advisory Board (ABCO) downgraded to Hold from Buy at Canaccord with analyst Richard Close citing the announced transaction to split the company by selling the Healthcare business to UnitedHealth's (UNH) Optum unit and the Education Business to Vista Equity Partners. 4. CubeSmart (CUBE) downgraded to Market Perform from Outperform at Raymond James with analyst Jonathan Hughes saying he expects CubeSmart's outsized exposure to New York City MSA will be remain a headwind to revenue growth given elevated new supply coming online over the next 12-18 months. 5. Vornado (VNO) downgraded to Hold from Buy at Stifel with analyst John Guinee saying the company's development pipeline "sounds intriguing" but is comprised entirely of 2019 and later deliveries, leaving Vornado lacking near-term catalysts. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
08/30/17
STFL
08/30/17
DOWNGRADE
STFL
Hold
Vornado downgraded to Hold from Buy at Stifel
08/30/17
08/30/17
DOWNGRADE
Target $77

Hold
Vornado downgraded to Hold as pipeline opportunities awaited at Stifel
As previously reported, Stifel analyst John Guinee downgraded Vornado to Hold from Buy, stating that the company's development pipeline "sounds intriguing" but is comprised entirely of 2019 and later deliveries, leaving Vornado lacking near-term catalysts. He cut his price target on the stock to $77 from $86.
09/19/17
SDLR
09/19/17
NO CHANGE
Target $90
SDLR
Buy
Toys 'R Us bankruptcy filing has no impact on Vornado, says Sandler ONeill
Sandler ONeill analyst Alexander Goldfarb noted that Vornado has already written its one-third stake in Toys 'R Us down to zero and has no financial obligations to the toy retailer, which means Toys' bankruptcy filing has no impact. The analyst, who separately trimmed his 2017 and 2018 FFO estimates for Vornado by 3c and 1c, respectively, keeps a Buy rating and $90 price target on the stock.
AMZN Amazon.com
$969.86

-4.33 (-0.44%)

09/20/17
KEYB
09/20/17
NO CHANGE
KEYB
Toys R Us bankruptcy positive for Wal-Mart, Amazon, says KeyBanc
KeyBanc analyst Edward Yruma views the Toys R Us (TOY) bankruptcy as positive for both Wal-Mart (WMT) and Amazon (AMZN). The analyst believes that Wal-Mart's toy and baby business is over two times Toys R Us' domestic business and that its relative importance to the toy companies will only increase. Meanwhile, Yruma thinks Amazon's growth and convenience will drive continued share gains as well.
09/19/17
KEYB
09/19/17
NO CHANGE
KEYB
KeyBanc remains positive on Activision Blizzard, Electronic Arts
KeyBanc analyst Evan Wingren remains positive on Activision Blizzard (ATVI), Electronic Arts (EA), and Take-Two (TTWO) after attending eSCon, a small eSports conference in Los Angeles. The analyst believes interest and momentum in the space remains high, and continues to think the majority of the economics in the industry will accrue to IP owners and scaled technology partners. Therefore, Wingren continues to see the publishers as well-positioned, as well as Amazon's (AMZN) Twitch, Google's (GOOG; GOOGL) YouTube, and Facebook (FB).
09/20/17
NRCS
09/20/17
NO CHANGE
NRCS
Henry Schein and Patterson concerns overdone, says Northcoast
Northcoast analyst Ed Snyder said Henry Schein (HSIC) and Patterson Companies (PDCO) have traded significantly lower in the past week due to concerns Amazon.com will increase exposure to the dental market. Snyder's research indicates Amazon is sourcing product from unsustainable sources including grey market sellers and privately-held Arnold Dental Supply, and not from large dental product manufacturers directly. He expects Arnold Dental to face increasing pressure from manufacturers who are annoyed product s are being sold via Amazon and notes many are not currently filling orders to replenish inventory. Further, Snyder said dentists value equipment service and support offered by traditional distributors far more than price discounts.
09/20/17
SBSH
09/20/17
NO CHANGE
Target $51
SBSH
Buy
Citi likes Kohl's swimming with the 'shark,' boosts target to $51
Citi analyst Paul Lejuez raised his price target for Kohl's (KSS) to $51 after the company announced its second partnership with Amazon (AMZN) this month. The collaboration, at a time when department stores are struggling, shows that Kohl's management is thinking out of the box, Lejuez tells investors in a research note. He believes the partnership can work to improve traffic. It is "better to be the 'pilot fish' that swims with the 'shark' than to be hunted by the shark," the analyst contends. He keeps a Buy rating on Kohl's.
WMT Wal-Mart
$80.29

0.24 (0.30%)

08/29/17
OPCO
08/29/17
NO CHANGE
OPCO
Whole Foods price cuts deep, not broad yet after Amazon deal, says Oppenheimer
Based on his analysis in New York City following Amazon (AMZN) acquisition, Oppenheimer analyst Rupesh Parikh notes Whole Foods (WFM) cut prices on select items by 22%, or $1.15 on average. The analyst would characterize Whole Foods' cuts as deep, but not broad yet. Parikh expects a heightened period of volatility for grocers to persist given competitive uncertainty, and says he does not expect Wal-Mart (WMT) and Kroger (KR) to let pricing gaps erode. As a result, the analyst would expect counter-reactions if need be to the extent Amazon gets aggressive on a basket of items versus just a few SKUs.
09/06/17
FBCO
09/06/17
NO CHANGE
Target $43
FBCO
Underperform
Campbell Soup, Wal-Mart still negotiating, says Credit Suisse
Following up on Campbell Soup's (CPB) public disagreement in the soup category with Wal-Mart (WMT), Credit Suisse analyst Robert Moskow says the dispute specifically relates to Wal-Mart's demands for lower everyday price points on Campbell's condensed soup products. While this dispute does not appear to involve General Mills' (GIS) Progresso brand or the ready-to-serve category at this time, the analyst notes that Wal-Mart presumably could threaten to give more shelf space to General Mills or its Great Value brand at Campbell's expense. Campbell and Wal-Mart are still negotiating, Moskow points out, adding that it may be a good thing for the stock if Campbell can get Wal-Mart to agree to a compromise. The analyst reiterates an Underperform rating and $43 price target on Campbell's shares.
09/07/17
WELS
09/07/17
NO CHANGE
WELS
Market Perform
Perrigo signaled willingness to work with Amazon, says Wells Fargo
Wells Fargo analyst David Maris noted that while presenting yesterday at the firm's conference, Perrigo (PRGO) said it would welcome working with Amazon on store brands. Currently, online sales partnerships with e-commerce arms of existing retailers, such as Walmart (WMT) and Walgreens (WBA), account for 1% of Perrigo products, he added. Maris, who said the company made an "upbeat and confident presentation," keeps a Market Perform rating on Perrigo shares.
JPM JPMorgan
$94.12

0.18 (0.19%)

08/09/17
WELS
08/09/17
INITIATION
Target $110
WELS
Outperform
JPMorgan resumed with an Outperform at Wells Fargo
Wells Fargo analyst Mike Mayo resumed coverage JPMorgan with an Outperform rating and $110 price target.
07/11/17
BARD
07/11/17
NO CHANGE
BARD
Big bank set-up not great, would sell into extended rally, says Baird
Baird analyst David George does not see a great set-up for money-center banks heading into Q2 earnings. He said the trade looks crowded and he would be a seller into an extended rally. George said the risk/reward is less attractive following the sector's most recent rally as economic growth remains muted and the pace of NIM expansion may slow. George believes the biggest potential catalyst would be a gradual steepening of the yield curve and pick-up on loan growth.
07/06/17
07/06/17
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Nike (NKE) initiated with an Outperform at Raymond James. 2. JPMorgan (JPM) initiated with a Neutral at Goldman Sachs. 3. At Home Group (HOME) initiated with a Buy at SunTrust. 4. Logitech (LOGI) initiated with a Buy at Citi. 5. Medtronic (MDT) initiated with an Outperform at William Blair. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
07/06/17
GSCO
07/06/17
INITIATION
Target $93
GSCO
Neutral
JPMorgan initiated with a Neutral at Goldman Sachs
Goldman analyst Richard Ramsden resumed coverage on JPMorgan with a Neutral and a $93 price target saying it is a best-in-class franchise with a premium multiple.

TODAY'S FREE FLY STORIES

STLD

Steel Dynamics

$37.78

1.34 (3.68%)

21:35
10/19/17
10/19
21:35
10/19/17
21:35
Upgrade
Steel Dynamics rating change at KeyBanc »

Steel Dynamics upgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Oct

RXDX

Ignyta

$16.65

0.4 (2.46%)

20:30
10/19/17
10/19
20:30
10/19/17
20:30
Syndicate
Ignyta 10M share Secondary priced at $16.00 »

The deal size was…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Nov

  • 20

    Oct

PG

Procter & Gamble

$91.59

-0.4904 (-0.53%)

, GE

General Electric

$23.58

0.46 (1.99%)

20:25
10/19/17
10/19
20:25
10/19/17
20:25
Earnings
Notable companies reporting before tomorrow's open »

Notable companies…

PG

Procter & Gamble

$91.59

-0.4904 (-0.53%)

GE

General Electric

$23.58

0.46 (1.99%)

HON

Honeywell

$143.62

0.18 (0.13%)

SLB

Schlumberger

$64.50

-1.41 (-2.14%)

STI

SunTrust

$59.11

-0.18 (-0.30%)

SYF

Synchrony

$31.71

0.2 (0.63%)

CFG

Citizens Financial

$37.43

0.25 (0.67%)

KSU

Kansas City Southern

$103.78

0.97 (0.94%)

GNTX

Gentex

$20.66

0.2 (0.98%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Oct

  • 20

    Oct

  • 20

    Oct

  • 20

    Oct

  • 20

    Oct

  • 20

    Oct

  • 20

    Oct

  • 20

    Oct

  • 20

    Oct

  • 22

    Oct

  • 02

    Nov

WILC

G. Willi-Food

$5.85

-0.14 (-2.34%)

18:35
10/19/17
10/19
18:35
10/19/17
18:35
Hot Stocks
G. Willi-Food receives notice from Arla Food ending distribution agreement »

G. Willi-Food's…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MIC

Macquarie Infrastructure

$71.26

-0.46 (-0.64%)

18:30
10/19/17
10/19
18:30
10/19/17
18:30
Hot Stocks
Macquarie Infrastructure CEO to become CEO of Macquarie Atlas Roads in 2018 »

Macquarie Infrastructure…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Nov

BIDU

Baidu

$264.52

-4.45 (-1.65%)

18:30
10/19/17
10/19
18:30
10/19/17
18:30
Hot Stocks
Baidu collaborating with China's BAIC Group and King Long for autonomous driving »

Baidu signed strategic…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Oct

IBKC

Iberiabank

$80.15

0.05 (0.06%)

18:27
10/19/17
10/19
18:27
10/19/17
18:27
Hot Stocks
IBERIABANK to acquire Gibraltar Private Bank & Trust »

IBERIABANK Corporation…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Oct

  • 15

    Nov

  • 28

    Nov

VBTX

Veritex

$27.04

-0.02 (-0.07%)

18:20
10/19/17
10/19
18:20
10/19/17
18:20
Hot Stocks
Veritex receives regulatory approval for Liberty Bancshares merger »

Veritex Holdings, the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

BHP

BHP Billiton

$41.56

0.06 (0.14%)

18:03
10/19/17
10/19
18:03
10/19/17
18:03
Hot Stocks
BHP Billiton CEO sees challenges around geopolitical uncertainty remaining »

In annual shareholder…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DRRX

Durect

$1.97

0.03 (1.55%)

17:59
10/19/17
10/19
17:59
10/19/17
17:59
Hot Stocks
Durect: Phase 3 clinical trial for POSIMIR did not meet primary endpoint »

Durect reported that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TTNP

Titan Pharmaceuticals

$1.90

-0.1 (-5.00%)

17:49
10/19/17
10/19
17:49
10/19/17
17:49
Hot Stocks
Titan Pharmaceuticals presents non-clinical data from liothyronine implant »

Titan Pharmaceuticals is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MSA

MSA Safety

$82.20

1.37 (1.69%)

17:46
10/19/17
10/19
17:46
10/19/17
17:46
Earnings
MSA Safety reports Q3 EPS 92c, consensus 80c »

Reports Q3 revenue $296M,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Oct

SKX

Skechers

$24.03

-1.06 (-4.22%)

, CAI

CAI International

$31.38

-0.05 (-0.16%)

17:41
10/19/17
10/19
17:41
10/19/17
17:41
Hot Stocks
On The Fly: After Hours Movers »

UP AFTER EARNINGS:…

SKX

Skechers

$24.03

-1.06 (-4.22%)

CAI

CAI International

$31.38

-0.05 (-0.16%)

PYPL

PayPal

$67.25

-0.01 (-0.01%)

MXIM

Maxim Integrated

$50.09

0.24 (0.48%)

IMDZ

Immune Design

$5.50

-1.05 (-16.03%)

NCR

NCR Corp.

$37.05

-0.26 (-0.70%)

TACO

Del Taco

$15.39

-0.01 (-0.06%)

ATHN

athenahealth

$116.41

-4.37 (-3.62%)

ISRG

Intuitive Surgical

$357.46

3.09 (0.87%)

ETFC

E-Trade

$43.69

-0.23 (-0.52%)

CELG

Celgene

$135.96

-1.21 (-0.88%)

PBMD

Prima BioMed

$2.36

-0.02 (-0.84%)

AAXN

Axon

$24.62

-0.37 (-1.48%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Oct

  • 19

    Oct

  • 19

    Oct

  • 19

    Oct

  • 19

    Oct

  • 19

    Oct

  • 19

    Oct

  • 19

    Oct

  • 19

    Oct

  • 20

    Oct

  • 21

    Oct

  • 22

    Oct

  • 26

    Oct

  • 28

    Oct

  • 06

    Nov

  • 06

    Nov

  • 07

    Nov

  • 08

    Nov

  • 29

    Nov

DGX

Quest Diagnostics

$93.23

1.18 (1.28%)

17:37
10/19/17
10/19
17:37
10/19/17
17:37
Hot Stocks
Quest Diagnostics acquires Cleveland HeartLab, terms not disclosed »

Advantage Capital…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Oct

  • 06

    Nov

  • 30

    Nov

AAXN

Axon

$24.62

-0.37 (-1.48%)

17:34
10/19/17
10/19
17:34
10/19/17
17:34
Hot Stocks
Axon says now aware of comment letter over SEC's review of 10-K, 10-Q »

Axon Enterprise said in a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BPMX

BioPharmX

17:29
10/19/17
10/19
17:29
10/19/17
17:29
Syndicate
Breaking Syndicate news story on BioPharmX »

BioPharmX files to sell…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MBVX

MabVax Therapeutics

$0.74

0.0248 (3.47%)

17:29
10/19/17
10/19
17:29
10/19/17
17:29
Syndicate
Breaking Syndicate news story on MabVax Therapeutics »

MabVax Therapeutics files…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IBKC

Iberiabank

$80.15

0.05 (0.06%)

17:28
10/19/17
10/19
17:28
10/19/17
17:28
Earnings
Iberiabank reports Q3 non-GAAP EPS $1.00, consensus $1.16 »

Reports Q3 core revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Oct

  • 15

    Nov

  • 28

    Nov

DRRX

Durect

$1.97

0.03 (1.55%)

17:28
10/19/17
10/19
17:28
10/19/17
17:28
Hot Stocks
Breaking Hot Stocks news story on Durect »

Durect trading halted,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

QCP

Quality Care Properties

$16.26

0.07 (0.43%)

17:26
10/19/17
10/19
17:26
10/19/17
17:26
Hot Stocks
Quality Care Properties provides update on HCR ManorCare »

Quality Care Properties…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FTR

Frontier Communications

$11.48

0.02 (0.17%)

, CHH

Choice Hotels

$68.45

0.25 (0.37%)

17:26
10/19/17
10/19
17:26
10/19/17
17:26
Hot Stocks
Frontier Communications named a Qualified Vendor with Choice Hotels Internationa »

Frontier Communications…

FTR

Frontier Communications

$11.48

0.02 (0.17%)

CHH

Choice Hotels

$68.45

0.25 (0.37%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    Oct

  • 06

    Nov

  • 08

    Nov

DRIO

DarioHealth

$1.98

-0.2 (-9.17%)

17:16
10/19/17
10/19
17:16
10/19/17
17:16
Syndicate
Breaking Syndicate news story on DarioHealth  »

DarioHealth files to sell…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CUBI

Customers Bancorp

$33.16

0.46 (1.41%)

17:11
10/19/17
10/19
17:11
10/19/17
17:11
Hot Stocks
Customers Bancorp to spin off BankMobile business »

Customers Bancorp plans…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Nov

  • 15

    Nov

MVC

MVC Capital

$10.40

0.08 (0.78%)

17:07
10/19/17
10/19
17:07
10/19/17
17:07
Hot Stocks
MVC Capital: Glass Lewis, Egan-Jones against proposal to cease new investments »

MVC Capital announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    Oct

CELG

Celgene

$135.96

-1.21 (-0.88%)

17:05
10/19/17
10/19
17:05
10/19/17
17:05
Hot Stocks
Breaking Hot Stocks news story on Celgene »

Celgene down 6.6% after…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Oct

  • 28

    Oct

  • 06

    Nov

  • 08

    Nov

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.